At a glance
- Originator Toa Eiyo
- Class Antiarrhythmics
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias
Most Recent Events
- 20 Jul 1998 Discontinued-Preclinical for Arrhythmias in Japan (Unknown route)
- 04 Feb 1998 New profile
- 04 Feb 1998 Preclinical development for Arrhythmias in Japan (Unknown route)